Booraphun Suchart, Hantrakun Viriya, Siriboon Suwatthiya, Boonsri Chaiyaporn, Poomthong Pulyamon, Singkaew Bung-Orn, Wasombat Oratai, Chamnan Parinya, Champunot Ratapum, Rudd Kristina, Day Nicholas P J, Dondorp Arjen M, Teparrukkul Prapit, West Timothy Eoin, Limmathurotsakul Direk
Department of Internal Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
BMJ Open. 2021 Feb 18;11(2):e041022. doi: 10.1136/bmjopen-2020-041022.
To evaluate the effectiveness of a Sepsis Fast Track (SFT) programme initiated at a regional referral hospital in Thailand in January 2015.
A retrospective analysis using the data of a prospective observational study (Ubon-sepsis) from March 2013 to January 2017.
General medical wards and medical intensive care units (ICUs) of a study hospital.
Patients with community-acquired sepsis observed under the Ubon-sepsis cohort. Sepsis was defined as modified Sequential Organ Failure Assessment (SOFA) Score ≥2.
The SFT programme was a protocol to identify and initiate sepsis care on hospital admission, implemented at the study hospital in 2015. Patients in the SFT programme were admitted directly to the ICUs when available. The non-exposed group comprised of patients who received standard of care.
The primary outcome was 28-day mortality. The secondary outcomes were measured sepsis management interventions.
Of 3806 sepsis patients, 903 (24%) were detected and enrolled in the SFT programme of the study hospital (SFT group) and 2903 received standard of care (non-exposed group). Patients in the SFT group had more organ dysfunction, were more likely to receive measured sepsis management and to be admitted directly to the ICU (19% vs 4%). Patients in the SFT group were more likely to survive (adjusted HR 0.72, 95% CI 0.58 to 0.88, p=0.001) adjusted for admission year, gender, age, comorbidities, modified SOFA Score and direct admission to the ICUs.
The SFT programme is associated with improved sepsis care and lower risk of death in sepsis patients in rural Thailand, where some critical care resources are limited. The survival benefit is observed even when all patients enrolled in the programme could not be admitted directly into the ICUs.
NCT02217592.
评估2015年1月在泰国一家区域转诊医院启动的脓毒症快速通道(SFT)项目的有效性。
采用2013年3月至2017年1月一项前瞻性观察研究(乌汶脓毒症研究)的数据进行回顾性分析。
研究医院的普通内科病房和内科重症监护病房(ICU)。
乌汶脓毒症队列中观察到的社区获得性脓毒症患者。脓毒症定义为改良序贯器官衰竭评估(SOFA)评分≥2。
SFT项目是一项在医院入院时识别并启动脓毒症治疗的方案,于2015年在研究医院实施。SFT项目中的患者在有空余床位时直接入住ICU。未暴露组由接受标准治疗的患者组成。
主要结局是28天死亡率。次要结局是测量脓毒症管理干预措施。
在3806例脓毒症患者中,903例(24%)被检测到并纳入研究医院的SFT项目(SFT组),2903例接受标准治疗(未暴露组)。SFT组患者有更多器官功能障碍,更有可能接受测量的脓毒症管理并直接入住ICU(19%对4%)。在对入院年份、性别、年龄、合并症、改良SOFA评分和直接入住ICU进行调整后,SFT组患者存活的可能性更大(调整后风险比0.72,95%置信区间0.58至0.88,p = 0.001)。
在泰国农村地区,一些重症监护资源有限,SFT项目与脓毒症患者脓毒症治疗的改善及死亡风险降低相关。即使该项目中所有登记患者不能直接入住ICU,仍观察到生存获益。
NCT02217592。